On the basis of the data analyzed above, 7 CHD candidate genes, including EGFR, EVC2, NFATC2, NR2F2, TBX5, CFC1B and GJA5, were chosen and validated for their methylation levels in the samples from 41 patients with TOF. This evidence concerns the gene NR2F2 and coronary artery disorder.